ARCHIVES

NCI Not Following Congress Mandate, Zubrod Contends

This article is from The Cancer Letter archive.

Vol. 04 No. 17 | April 28, 1978

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

NCI Raises R01 Payline To 16th Percentile FY09. Coalition Formed To Advocate For Medical Innovation

March 27, 2009

ACS Asks Higher NCI Authorization

March 24, 1978

NCAB Honors Member Who Was In Stockholm

December 9, 1988

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000